50% off Premium Yearly

NASDAQ:TGTX
TG Therapeutics is a American stock, trading under the symbol TGTX (previously TGTX-Q on Stockchase) on the NASDAQ (TGTX). It is usually referred to as NASDAQ:TGTX or TGTX
In the last year, no analyst issued a Buy, Sell, or Hold rating on TGTX (previously TGTX-Q on Stockchase) on Stockchase. Read the latest expert commentary for TG Therapeutics.
TG Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for TG Therapeutics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for TG Therapeutics.
TG Therapeutics is followed by 9 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-12, TG Therapeutics (TGTX) stock closed at a price of $49.52.
Developing drugs for MS and blood cancers like leukemia. Exciting prospects; boasts promising clinical trial results, especially for their MS drug. Last month, they announced good phase 3 results for that drug which lifted share from the $30's to $50's. Cash flow is fine; they just said they've raised a lot of money.